Intravitreal triamcinolone acetonide for exudative age related macular degeneration

No abstract is available for this paper.

• Publication year

  2003

• Venue

  British Journal of Ophthalmology

• Publication date

  2003-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjo.87.4.462PMID 12642311PMCID PMC1771586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization

  2005cited by this paper
• Intravitreal injection of triamcinolone acetonide for diabetic macular edema.

  2004cited by this paper
• Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

  2004cited by this paper
• Intraocular pressure after intravitreal injection of triamcinolone acetonide

  2003cited by this paper
• Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

  2003cited by this paper
• Surgical performance for specialties undertaking temporal artery biopsies: who should perform them?

  2003cited by this paper
• Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration

  2002cited by this paper
• Liposarcoma of the orbit presenting as an enlarged medial rectus muscle on CT scan

  2002cited by this paper
• Ophthalmic artery occlusion following pars plana vitrectomy in a patient with Terson's syndrome

  2002cited by this paper
• Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C

  2002cited by this paper
• Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration

  2002cited by this paper
• Intravitreal triamcinolone in recurrence of choroidal neovascularisation

  2002cited by this paper
• Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

  2002cited by this paper
• Intravitreal triamcinolone for refractory diabetic macular edema.

  2002cited by this paper
• Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil

  2002cited by this paper
• TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH PHOTODYNAMIC THERAPY (TAP) STUDY GROUP. PHOTODYNAMIC THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH VERTEPORFIN: TWO-YEAR RESULTS OF 2 RANDOMIZED CLINICAL TRIALS-TAP REPORT 2

  2001cited by this paper
• The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.

  2001cited by this paper
• Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

  2001cited by this paper
• Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy.

  2001cited by this paper
• Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

  2001cited by this paper
• Regression of Neovascular Iris Vessels by Intravitreal Injection of Crystalline Cortisone

  2001cited by this paper
• Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

  2001cited by this paper
• Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony

  2001cited by this paper
• Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

  2001cited by this paper
• Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy.

  2001cited by this paper
• Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC‐II in exudative age‐related macular degeneration

  2001cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE‐RELATED MACULAR DEGENERATION

  2000cited by this paper
• Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.

  2000cited by this paper
• Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

  2000cited by this paper
• Triamcinolone acetonide modulates permeability and intercellular adhesion molecule‐1 (ICAM‐1) expression of the ECV304 cell line: implications for macular degeneration

  2000cited by this paper
• Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.

  2000cited by this paper
• Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.

  2000cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Ophthalmoscopic evaluation of the optic nerve head.

  1999cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin One-Year Results of 2 Randomized Clinical Trials—TAP Report

  1999cited by this paper
• Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

  1999cited by this paper
• Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

  1999cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

  1999cited by this paper
• An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.

  1998cited by this paper
• Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

  1998cited by this paper
• Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.

  1996cited by this paper
• Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

  1996cited by this paper
• Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye.

  1996cited by this paper
• Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

  1995cited by this paper
• Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

  1995cited by this paper
• The prevalence of age-related maculopathy in the Rotterdam Study.

  1995cited by this paper
• Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection.

  1992cited by this paper
• Age-related macular degeneration.

  1988cited by this paper
• Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations.

  1986cited by this paper
• Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate.

  1985cited by this paper
• The lack of toxicity of intravitreally administered triamcinolone acetonide.

  1981cited by this paper
• Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

  1980cited by this paper
• Inhibition of intraocular proliferations with intravitreal corticosteroids.

  1980cited by this paper
• Treatment of intraocular proliferations with intravitreal steroids.

  1979cited by this paper
• Bulbar perforation during periocular injection of corticosteroids.

  1974cited by this paper

• The Role of Inflammation in Age-Related Macular Degeneration.

  2025cites this paper
• Perspectives on the currently available pharmacotherapy for wet macular degeneration

  2024cites this paper
• Enhanced Ocular Bioavailability and Prolonged Duration via Hydrophilic Surface Nanocomposite Vesicles for Topical Drug Administration

  2024cites this paper
• Central posterior hyaloid fibrosis: evolution and outcomes

  2023cites this paper
• The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems

  2023cites this paper
• The Protection and Antioxidant Mechanisms of Corticosteroids in LPSTreated Retinal Pigment Epithelial Cells

  2023cites this paper
• Retinal fluid is associated with cytokines of aqueous humor in age-related macular degeneration using automatic 3-dimensional quantification

  2023cites this paper
• BRIDGE ARCH–SHAPED SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2022cites this paper
• The retinal pigment epithelium

  2021cites this paper
• Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy

  2020cites this paper
• retina-VAE: Variationally Decoding the Spectrum of Macular Disease

  2019cites this paper
• A Study on Intraocular Pressure Elevation after Intravitreal 4mg Triamcinolone Acetonide Injection in Treatment of Macular Edema among North India Population

  2019cites this paper
• Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium-Role in Dead Cell Clearance and Inflammation

  2019cites this paper
• Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries

  2018cites this paper
• ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA

  2017cites this paper
• Vision Preservation in Eyes of Polypoidal Choroidal Vasculopathy with Low-Dose Intravitreal Triamcinolone Acetonide

  2017cites this paper
• Efficacy and Safety of Combined Intravitreal Bevacizumab and Retrobulbar Corticosteroids for Neovascular Age-Related Macular Degeneration

  2017cites this paper
• tinue to seek treatment and unnecessary tests, and the cycle will likely continue.

  2017cites this paper
• New Therapy for Central Retinal Vein Occlusion

  2017cites this paper
• Optimizing cataract surgery in patients with age-related macular degeneration.

  2017cites this paper
• Triamacinolone acetonide versus bevacizumab in treatment of neovascular age related macular degeneration

  2017influential citation
• Should Corticosteroids Be Considered as Part of the Standard Care With Photodynamic Therapy

  2017cites this paper
• likely to reduce medical utilization.

  2017cites this paper
• Intravitreal Steroid Implants in the Management of Retinal Disease and Uveitis

  2016cites this paper
• The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema

  2016cites this paper
• Clearance of autophagy-associated dying retinal pigment epithelial cells – a possible source for inflammation in age-related macular degeneration

  2016influential citation
• Comparison of Bevacizumab and Combined Low-dose Bevacizumab and Triamcinolone in Central Retinal Vein Occlusion

  2016cites this paper
• Intravitreal Triamcinolone Injection in Patients With Surgically Controlled Glaucoma

  2016cites this paper
• A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration

  2016cites this paper
• Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone.

  2016cites this paper
• Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: Pilot study ,

  2016cites this paper
• In vitro investigation of the clearance of anoikic and autophagy-associated dying retinal pigment epithelial cells – implications for age-related macular degeneration by Mária Szatmári-Tóth

  2016cites this paper
• TO EVALUATE THE EFFECT OF INTRAVITREAL INJECTION OF TRIAMCINOLONE ACETONIDE IN RECALCITRANT MACULAR DISORDERS.

  2015influential citation
• Evaulation of Incidence and Risk Factors for Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection

  2015cites this paper
• Effect of Posterior Subtenon Triamcinolone Injection during Vitrectomy for Idiopathic Epiretinal Membrane

  2015cites this paper
• Uloga kortikosteroida u liječenju makularnih bolesti

  2015cites this paper
• Current nanotechnology approaches for the treatment and management of diabetic retinopathy.

  2015cites this paper
• Cationic Lipid Nanomedicines for the treatment of Diabetic retinopathy

  2015cites this paper
• Age-Related Macular Degeneration: A Scientometric Analysis

  2015cites this paper
• Severe intraocular pressure rise following intravitreal triamcinolone: a national survey to estimate incidence and describe case profiles

  2014cites this paper
• Investigations into Drug Delivery to the Eye: Nanoparticle Comparisons

  2014cites this paper
• Choroidal Neovascularization Induces Retinal Edema and its Treatment Addresses this Problem

  2014cites this paper
• Retinal injury thresholds for 532, 578, and 630 nm lasers in connection to photodynamic therapy for choroidal neovascularization

  2014cites this paper
• The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration.

  2014cites this paper
• [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].

  2013cites this paper
• THE DURATION OF EFFECT OF CENTRIFUGE CONCENTRATED INTRAVITREAL TRIAMCINOLONE ACETONIDE

  2013cites this paper
• Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema

  2013cites this paper
• Diffusion of technologies for the care of older adults with exudative age-related macular degeneration.

  2013cites this paper
• Posterior Subtenon Triamcinolone Acetonide in Gas-filled Eyes as an Adjunctive Treatment for Complicated Proliferative Diabetic Retinopathy

  2013cites this paper
• Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.

  2013cites this paper
• Intraocular pressure monitoring post intravitreal steroids: a systematic review.

  2013cites this paper
• Hypothalamic–pituitary–adrenal axis function following intravitreal triamcinolone acetonide injection

  2013cites this paper
• Intraocular Pressure Changes after Triamcinolone Acetonide Intravitreal Injection Introduction INJECTION

  2013cites this paper
• Safety of intravitreal triamcinolone acetonide: an electrophysiologic and histopathological study in rabbits.

  2013cites this paper
• Age-related macular degeneration

  2012cites this paper
• Optical Coherence Tomography and Visual Acuity: Photoreceptor Loss

  2012cites this paper
• Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevation.

  2012cites this paper
• [Triamcinolone acetonide without solvents].

  2012cites this paper
• Intraocular corticosteroids for posterior segment disease: 2012 update

  2012cites this paper
• Triamcinolone acetonide without solvents

  2012cites this paper
• New Pharmacologic Approaches to Therapy for Age-Related Macular Degeneration

  2012cites this paper
• Acetónido de triamcinolona sin conservantes

  2012cites this paper
• Inflammation in Age-Related Macular Degeneration – Implications for Therapy

  2012cites this paper
• Intravitreal Bevacizumab After Intravitreal Triamcinolone for Exudative Age-Related Macular Degeneration

  2012cites this paper
• The Effects of Glucocorticoids on Fetal and Placental Development

  2012cites this paper
• Combination Treatment Strategies in Neovascular AMD

  2012cites this paper
• PRESERVATIVE-FREE TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION VERSUS “TRADITIONAL” TRIAMCINOLONE PREPARATIONS: Impact of Aggregate Size on Retinal Biocompatibility

  2011cites this paper
• BEYOND AREDS : THE TOZAL STUDY – A PARADIGM SHIFT IN THE TREATMENT OF AMD

  2011cites this paper
• Retinal pigment epithelial tear after intravitreous triamcinolone acetonide injection for fibrovascular pigment epithelial detachment.

  2011cites this paper
• Therapie der exsudativen altersbedingten Makuladegeneration (AMD) mittels intravitrealem Triamcinolon und in Kombination mit photodynamischer Therapie (PDT)

  2011cites this paper
• Does lens status affect the course of early intraocular pressure and anterior chamber changes after intravitreal injection?

  2011influential citation
• Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

  2011cites this paper
• Ocular Pharmacokinetics of Mapracorat, a Novel, Selective Glucocorticoid Receptor Agonist, in Rabbits and Monkeys

  2011cites this paper
• The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

  2011cites this paper
• INTRAVITREAL BEVACIZUMAB VERSUS COMBINED INTRAVITREAL BEVACIZUMAB AND TRIAMCINOLONE FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Six-Month Results of a Randomized Clinical Trial

  2011cites this paper
• Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.

  2011cites this paper
• The Intravitreal Use of Corticosteroids - Balancing Benefit and Risk

  2011cites this paper
• EARLY CHANGE OF CENTRAL MACULAR THICKNESS AFTER INTRAVITREOUS TRIAMCINOLONE OR BEVACIZUMAB IN DIABETIC MACULAR EDEMA OR RETINAL VEIN OCCLUSION

  2011cites this paper
• RISK FACTORS FOR ENDOGENOUS ENDOPHTHALMITIS SECONDARY TO KLEBSIELLA PNEUMONIAE LIVER ABSCESS: 20-Year Experience in Southern Taiwan

  2011cites this paper
• acetonide for branch retinal vein occlusion intraoperative intravitreal triamcinolone Combined arteriovenous sheathotomy and

  2010cites this paper
• Le Ranibizumab Intravitreen induit une vasoconstriction artérielle rétinienne chez les patients présentant une dégénérence maculaire liée à l'âge néovasculaire

  2010cites this paper
• [Study of visual acuity and intraocular pressure in the treatment of macular diabetic edema with intravitreous triamcinolone].

  2010cites this paper
• Steroids and the Management of Macular Edema

  2010cites this paper
• [Retinal neovascularization and its therapeutic agents].

  2010cites this paper
• Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization

  2010influential citation
• Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application.

  2010cites this paper
• Pharmacological Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration

  2010cites this paper
• Bevacizumab in der Therapie der altersabhängigen Makuladegeneration - funktionelle und morphologische Ergebnisse

  2010cites this paper
• Intravitreal Triamcinolone

  2010cites this paper
• Intraocular lens short wavelength light filtering

  2010cites this paper
• Evaluation of different preparation methods for a preservative free triamcinolone acetonide preparation for intravitreal administration: a validated stability indicating HPLC-method.

  2010cites this paper
• Retinal and Ocular Toxicity in Ocular Application of Drugs and Chemicals – Part II: Retinal Toxicity of Current and New Drugs

  2010cites this paper
• MICROPERIMETRIC CHANGES AFTER INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTION FOR MACULAR EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION

  2010cites this paper
• The intravitreal use of corticosteroids

  2010cites this paper
• Inhibition of choroidal neovascularization by intravitreal ketorolac.

  2010cites this paper
• Update on combination therapy in wet age-related macular degeneration

  2010cites this paper
• Effects of Photodynamic Therapy Using Hematoporphyrin Monomethyl Ether on Experimental Choroidal Neovascularization

  2010cites this paper
• [Triple therapy for the treatment of choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration].

  2010cites this paper
• Pars-plana-Vitrektomie mit ILM-Peeling versus intravitreale Triamcinolon-Injektion bei diffusem diabetischem Makulaödem

  2010cites this paper
• Central Retinal Artery Perfusion following 0.1 ml Intravitreal Injection of Bevacizumab

  2009cites this paper